A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Changes in Opioid Use Outcomes After Passage of Medical Marijuana Laws Jan. 13, 2025 — A new study found no changes in opioid outcomes among the general population with the states' passage of ...

A Vanderbilt researcher has been awarded $6.2 million to study the effect of opioids on the brain.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...